BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26973058)

  • 21. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway.
    Iversen T; Tretli S
    Obstet Gynecol; 1998 Jun; 91(6):969-72. PubMed ID: 9611006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease.
    Farias-Eisner R; Cirisano FD; Grouse D; Leuchter RS; Karlan BY; Lagasse LD; Berek JS
    Gynecol Oncol; 1994 Apr; 53(1):55-8. PubMed ID: 8175023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral lymphatic vessel density in vulvar squamous cell carcinomas: a possible association with favorable prognosis.
    Goes RS; Carvalho JP; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho FM
    Int J Gynecol Pathol; 2012 Jan; 31(1):8-14. PubMed ID: 22123718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma.
    Schuurman MS; van den Einden LC; Massuger LF; Kiemeney LA; van der Aa MA; de Hullu JA
    Eur J Cancer; 2013 Dec; 49(18):3872-80. PubMed ID: 24011936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on vulvar cancer.
    Ghurani GB; Penalver MA
    Am J Obstet Gynecol; 2001 Aug; 185(2):294-9. PubMed ID: 11518882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
    Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
    Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the sentinel lymph node procedure in vulvar cancer.
    Oonk MH; van de Nieuwenhof HP; van der Zee AG; de Hullu JA
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):61-9. PubMed ID: 20014886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
    Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL
    Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vulvar carcinoma.
    Anderson JM; Cassady JR; Shimm DS; Stea B
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1351-7. PubMed ID: 7635775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
    Bokhman JV; Maximov SJ; Ebert AD
    Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Individualized surgical therapy of vulvar carcinoma].
    Schwarz R
    Zentralbl Gynakol; 1996; 118(6):350-3. PubMed ID: 8768012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pitfalls in the sentinel lymph node procedure in vulvar cancer.
    de Hullu JA; Oonk MH; Ansink AC; Hollema H; Jager PL; van der Zee AG
    Gynecol Oncol; 2004 Jul; 94(1):10-5. PubMed ID: 15262113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands.
    Pleunis N; Schuurman MS; Van Rossum MM; Bulten J; Massuger LF; De Hullu JA; Van der Aa MA
    Gynecol Oncol; 2016 Sep; 142(3):440-5. PubMed ID: 27126004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible.
    van Doorn HC; van Beekhuizen HJ; Gaarenstroom KN; van der Velden J; van der Zee AG; Oonk MH; de Hullu JA
    Gynecol Oncol; 2016 Mar; 140(3):415-9. PubMed ID: 26797295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radical surgical treatment of epidermoid vulvar cancer. Results of ten years experience].
    Abboud J; Attieh E; Atallah D; Dergham S
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(6):595-9. PubMed ID: 8830077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenging the concept of microinvasive carcinoma of the vulva: report of a case with regional lymph node recurrence and review of the literature.
    Sidor J; Diallo-Danebrock R; Eltze E; Lellé RJ
    BMC Cancer; 2006 Jun; 6():157. PubMed ID: 16774683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery.
    Magrina JF; Gonzalez-Bosquet J; Weaver AL; Gaffey TA; Webb MJ; Podratz KC; Cornella JL
    Gynecol Oncol; 1998 Oct; 71(1):116-21. PubMed ID: 9784331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy.
    Terada KY; Shimizu DM; Jiang CS; Wong JH
    Gynecol Oncol; 2006 Aug; 102(2):200-3. PubMed ID: 16406504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating vulvar cancer in the new millennium: are patients receiving optimal care?
    Barbera L; Thomas G; Elit L; Covens A; Fyles A; Osborne R; Yun L
    Gynecol Oncol; 2008 Apr; 109(1):71-5. PubMed ID: 18234304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era.
    Landrum LM; Lanneau GS; Skaggs VJ; Gould N; Walker JL; McMeekin DS; Gold MA
    Gynecol Oncol; 2007 Sep; 106(3):521-5. PubMed ID: 17540438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.